Misdiagnosis of heart failure for Amlodipine adverse reaction

dc.contributor.authorBesa, C.
dc.date.accessioned2018-10-04T16:06:56Z
dc.date.available2018-10-04T16:06:56Z
dc.date.issued2017
dc.descriptionMisdiagnosis of heart failure for amlodipine related adverse reaction.en
dc.description.abstractThis is a case report of misdiagnosis of heart failure for amlodipine related adverse reaction. Amlodipine is a dihydropyridine calcium channel blocker frequently used in drug treatment of essential hypertension. Adverse reactions of calcium channel blockers are well documented yet the attending physician did not recognise ankle oedema as an adverse drug reaction of amlodipine. Instead, a differential diagnosis of heart was made. If the diagnosis of heart failure was maintained, this would have easily led to inappropriate use of multiple drugs and related problems such as non-adherence to treatment, duplication of treatment, additional adverse reactions and drug-drug interactions. This report has demonstrated poor understanding of the basic principles of clinical pharmacology and therapeutics (CPT) by the attending physician that could have threatened patient’s safety.en
dc.description.sponsorshipOffice of Global AIDS/US Department of Stateen
dc.identifier.citationBesa C. ( 2017). Misdiagnosis of heart failure for Amlodipine adverse reaction. Health Press Zambia Bull.en
dc.identifier.urihttp://dspace.unza.zm/handle/123456789/5439
dc.language.isoenen
dc.publisherHealth Press Zambia Bull.en
dc.relation.ispartofseriesVol.1;(2)
dc.subjectHeart failure--Zambiaen
dc.subjectAmlodipine--Zambiaen
dc.titleMisdiagnosis of heart failure for Amlodipine adverse reactionen
dc.typeTechnical Reporten
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Misdiagnosis of heart failure for Amlodipine adverse reaction.pdf
Size:
347.18 KB
Format:
Adobe Portable Document Format
Description:
Report
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description: